Evidence map›Paper›PMID 37798921›Full record

ArticleEpilepsia open2024

Characterization of low-grade epilepsy-associated tumor from implanted stereoelectroencephalography electrodes.

Taylor A Gatesman, Jasmine L Hect, H Westley Phillips, Brenden J Johnson, Abigail I Wald, Colleen McClung, Marina N Nikiforova, John M Skaugen, Ian F Pollack, Taylor J Abel and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Epilepsia open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Disease insights from brain somatic mosaicism.Experimental & molecular medicine · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Taylor A GatesmanDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-7456-7996
Jasmine L HectDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
H Westley PhillipsDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0003-0512-4590
Brenden J JohnsonDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Abigail I WaldMolecular and Genomic Pathology, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA.
Colleen McClungDepartment of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Marina N NikiforovaMolecular and Genomic Pathology, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA.
John M SkaugenMolecular and Genomic Pathology, University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA.
Ian F PollackDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Taylor J AbelDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.ORCID 0000-0002-5089-460X
Sameer AgnihotriDepartment of Neurological Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
University of Pittsburgh · USUPMC Health System · US

Funding

Metabolic Regulation of Glioblastoma EpitranscriptomicsR01CA268634 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Sameer Agnihotri, JEREMY N RICH · 2022 to 2026
$2.9M
Targeting extracellular signaling-regulated kinase 5 (ERK5) in brain tumors and their microenvironmentR01NS115831 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AGNIHOTRI, SAMEER · 2020 to 2024
$1.8M
Circadian analysis of peripheral and brain samples in epilepsy patientsR21NS127064 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ABEL, TAYLOR JOHN, MCCLUNG, COLLEEN A · 2022 to 2023
$418k
NCI NIH HHS CA268634NCI NIH HHS R01 CA268634NINDS NIH HHS R01 NS115831NINDS NIH HHS R21 NS127064
6 · The paper itself

Abstract

Low-grade epilepsy-associated tumors (LEATs) are a common cause of drug-resistant epilepsy in children. Herein, we demonstrate the feasibility of using tumor tissue derived from stereoelectroencephalography (sEEG) electrodes upon removal to molecularly characterize tumors and aid in diagnosis. An 18-year-old male with focal epilepsy and MRI suggestive of a dysembryoplastic neuroepithelial tumor (DNET) in the left posterior temporal lobe underwent implantation of seven peri-tumoral sEEG electrodes for peri-operative language mapping and demarcation of the peri-tumoral ictal zone prior to DNET resection. Using electrodes that passed through tumor tissue, we show successful isolation of tumor DNA and subsequent analysis using standard methods for tumor classification by DNA, including Glioseq targeted sequencing and DNA methylation array analysis. This study provides preliminary evidence for the feasibility of molecular diagnosis of LEATs or other lesions using a minimally invasive method with microscopic tissue volumes. The implications of sEEG electrodes in tumor characterization are broad but would aid in diagnosis and subsequent targeted therapeutic strategies.

Indexed as

Brain NeoplasmsEpilepsyAdolescentChildDNAElectrodes, ImplantedElectroencephalographyHumansMaleDNALEATsmethylationmutationsEEG

Identifiers

PMID37798921
PMCPMC10839351
OpenAlexW4387392488

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.